Profile data is unavailable for this security.
About the company
Hanshang Group Co Ltd, formerly Wuhan Hanshang Group Co Ltd is a China-based company principally engaged in the retail of commodities. The Company is also engaged in the exhibition business, hotel business, tourism business and property management business. The Company mainly operates its retail business through department stores, shopping malls and specialty stores. The Company mainly operates 21st Century Shopping Mall, Ginza Mall and Wuzhan Shopping Center.
- Revenue in CNY (TTM)1.36bn
- Net income in CNY49.62m
- Incorporated1990
- Employees2.38k
- LocationHanshang Group Co LtdNo. 134, Hanyang AvenueWUHAN 430050ChinaCHN
- Phone+86 2 768849191
- Fax+86 2 784842384
- Websitehttp://www.whhsg.com
More ▼
Mergers & acquisitions
Acquired company | 600774:SHH since announced | Transaction value |
---|---|---|
Zhen An (Wuhan) Company Ltd | -23.27% | -- |
Wuhan Zall City Investment Development Co Ltd-Assets | -23.27% | -- |
Data delayed at least 15 minutes, as of Jun 07 2024.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GuiZhou YiBai Pharmaceutical Co., Ltd. | 2.71bn | -9.06m | 2.62bn | 5.51k | -- | 0.874 | -- | 0.9675 | -0.0114 | -0.0114 | 3.42 | 3.79 | 0.56 | 1.47 | 11.26 | 491,815.10 | -0.4457 | 0.8618 | -0.6067 | 1.17 | 66.49 | 74.87 | -0.7958 | 1.45 | 1.32 | 1.67 | 0.2392 | 216.36 | 3.12 | -6.19 | 124.25 | -- | -16.51 | -- |
Beijing Hotgen Biotech Co Ltd | 454.44m | -26.45m | 2.68bn | 1.04k | -- | 0.7904 | -- | 5.90 | -0.3093 | -0.3093 | 5.14 | 36.65 | 0.1264 | 1.64 | 6.32 | 438,645.70 | -1.04 | 29.65 | -1.11 | 34.70 | 50.71 | 56.08 | -8.25 | 32.26 | 5.50 | -- | 0.0027 | 41.92 | -84.78 | 23.67 | -97.10 | -10.67 | 57.98 | -- |
Hanshang Group Co Ltd | 1.36bn | 49.62m | 2.70bn | 2.38k | 53.61 | 1.57 | -- | 1.98 | 0.1707 | 0.1707 | 4.65 | 5.84 | 0.3705 | 2.75 | 8.35 | 573,421.20 | 1.16 | 2.00 | 1.92 | 3.89 | 58.35 | 57.24 | 3.13 | 4.89 | 0.3366 | 2.15 | 0.3198 | 15.03 | 0.1893 | 5.14 | -32.24 | 25.62 | 12.88 | -- |
Chemclin Diagnostics Co Ltd | 455.80m | 150.93m | 2.70bn | 731.00 | 17.91 | 1.95 | -- | 5.93 | 0.3764 | 0.3764 | 1.14 | 3.45 | 0.2684 | 1.02 | 17.03 | 623,526.50 | 8.89 | 11.01 | 9.82 | 12.32 | 74.73 | 74.19 | 33.11 | 31.07 | 5.09 | -- | 0.1518 | 36.64 | -4.28 | 4.00 | -3.44 | -- | 44.10 | -- |
Shanghai MicuRx Pharmaceutical Co Ltd | 106.52m | -467.10m | 2.75bn | 205.00 | -- | 3.71 | -- | 25.84 | -0.7129 | -0.7129 | 0.1626 | 1.13 | 0.0839 | 0.5802 | 5.74 | 519,588.20 | -36.81 | -- | -40.09 | -- | 81.75 | -- | -438.53 | -- | 6.94 | -- | 0.2497 | -- | 88.31 | -- | -91.16 | -- | -- | -- |
ChengDu Sheng Nuo Biotec Co Ltd | 457.56m | 72.78m | 2.78bn | 1.13k | 38.06 | 3.10 | -- | 6.07 | 0.651 | 0.651 | 4.09 | 8.00 | 0.3505 | 0.9497 | 4.57 | 405,639.80 | 5.57 | 7.47 | 7.00 | 9.44 | 62.46 | 70.52 | 15.90 | 15.82 | 1.28 | 16.72 | 0.2495 | 21.83 | 9.93 | 9.37 | 9.08 | 18.69 | 54.71 | -- |
Shanghai Aladdin Biochemical Tech Co Ltd | 414.81m | 85.68m | 2.82bn | 566.00 | 28.18 | 2.67 | -- | 6.79 | 0.3602 | 0.3602 | 1.38 | 3.80 | 0.2803 | 0.3898 | 9.21 | 732,874.10 | 5.79 | 8.83 | 6.20 | 9.61 | 60.08 | 61.49 | 20.66 | 26.85 | 8.00 | -- | 0.2519 | 45.71 | 6.55 | 19.36 | -7.48 | 9.95 | 31.41 | -- |
Hinova Pharmaceuticals Inc | 0.00 | -266.00m | 2.82bn | 179.00 | -- | 2.13 | -- | -- | -2.69 | -2.69 | 0.00 | 13.39 | 0.00 | 105.68 | -- | 0.00 | -17.03 | -31.86 | -18.39 | -37.18 | -- | -- | -- | -25,578.24 | 11.83 | -- | 0.0097 | -- | -100.00 | -- | 2.44 | -- | 124.37 | -- |
Data as of Jun 07 2024. Currency figures normalised to Hanshang Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
Gfund Management Co., Ltd.as of 31 Dec 2023 | 1.11m | 0.49% |
Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 653.73k | 0.29% |
Western Leadbank Fund Management Co., Ltdas of 31 Dec 2023 | 613.30k | 0.27% |
Broad Fund Management Co. Ltd.as of 31 Dec 2023 | 612.80k | 0.27% |
E Fund Management Co., Ltd.as of 31 Dec 2023 | 204.70k | 0.09% |
Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 96.10k | 0.04% |
HFT Investment Management Co., Ltd.as of 31 Dec 2023 | 75.20k | 0.03% |
Changjiang Securities (Shanghai) Asset Management Co., Ltd.as of 31 Dec 2023 | 53.80k | 0.02% |
Bank of China Investment Management Co., Ltd.as of 31 Dec 2023 | 52.40k | 0.02% |
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 38.40k | 0.02% |
More ▼
Data from 31 Dec 2023 - 06 Jun 2024Source: FactSet Research Systems Inc.